The current PE ratio of LIVN can't be determined, as the TTM EPS of -$0.59 is negative. The most recent PE ratio recorded for LivaNova was 156.79 in December 2023.
Year | PE ratio | Change |
---|---|---|
2023 | 156.79 | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
OFIX Orthofix Medical Inc | N/A | $619.61M |
NVRO Nevro Corp | N/A | $357.74M |
LIVN LivaNova PLC | N/A | $2.9B |
The current price to earnings ratio of LIVN can't be calculated, as its EPS of -$0.59 is negative.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.